The House Voted To Let VA Doctors Recommend Cannabis. ‘It’s Policy Theater,’ Says The Guy Who’s Helped 1,000 Vets Get Cards.

The U.S. House voted last Thursday to let VA doctors recommend medical cannabis to military veterans. Most of the cannabis industry is celebrating. Robb Harmon, who has helped over 1,000 veterans navigate the medical card process through Veterans Cannabis Care, says the vote solves less than people think.

On May 14, the U.S. House of Representatives passed an amendment from Reps. Brian Mast (R-FL), Dave Joyce (R-OH) and Dina Titus (D-NV) that would block the Department of Veterans Affairs from enforcing a longstanding directive preventing VA providers from helping veterans register for state medical cannabis programs. The amendment, attached to the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, passed by a voice vote.

Under current policy, VA doctors are allowed to discuss cannabis with their patients but are barred from completing the paperwork needed to enroll them in state programs. As Marijuana Moment reported, veterans currently have to seek outside, often expensive, services from separate providers to obtain medical cannabis access. The Mast-Joyce-Titus amendment, if it survives reconciliation and is enacted into law, would change that.

The cannabis industry and veteran advocacy groups have largely greeted the vote as a long-overdue win. Mast, himself a combat veteran who lost two legs and a finger in Afghanistan, spoke on the floor about waking up in the hospital on a regimen of antidepressants, anti-inflammatories, sedatives and narcotic painkillers. He framed the amendment as a basic question of whether wounded service members deserve to have the same conversation with their doctor that civilians can have with theirs.

None of that is wrong. But Harmon, whose organization has spent years walking veterans through the actual mechanics of obtaining and renewing a state medical card, says the recommendation itself was never really the bottleneck.

“A recommendation without infrastructure creates delay. A recommendation without support creates abandonment. And a recommendation without real access is not progress, it’s policy theater.”

Robb Harmon, founder, Veterans Cannabis Care

The gaps inside the VA

The first problem, according to Harmon, is that the amendment removes the prohibition but does nothing to ensure VA physicians will actually participate. Even with the directive gone, individual doctors retain discretion to refuse to recommend cannabis. Many will. The institutional culture inside the VA has spent decades treating cannabis as off-limits, and that culture does not reset on the date the bill is enacted.

The second problem is training. There is no formal cannabinoid education in standard VA physician curriculum, no continuing education infrastructure, no treatment guidance built around the population the VA actually serves. A VA doctor who is suddenly allowed to recommend cannabis is not the same as a VA doctor who knows how to. Harmon argues that without a corresponding investment in clinical education, the population of veterans who can actually get a recommendation from their primary VA provider will remain small, concentrated in pockets where individual physicians have done their own homework.

The gaps outside the VA

The recommendation is the first step. After that, the veteran still has to navigate the state medical cannabis program where they live. State registration systems vary widely in cost, complexity, processing time and documentation requirements. Some require in-person appointments. Some require notarized forms. Some run on portals that go down for weeks at a time. Harmon’s organization has spent years helping veterans through systems that were not designed with disabled, rural or fixed-income users in mind.

Then there is renewal. Medical cards in most states expire annually and require recertification, additional fees and, in some cases, a fresh physician visit. For veterans on a fixed income, those costs are not trivial. For veterans with mobility limitations, the in-person appointment requirements alone can be disqualifying. Harmon describes a steady pattern of veterans falling out of compliance not because they no longer need the medicine but because the system makes staying in compliance harder than getting in the first place.

What happens when access lapses

The downstream consequence is the part of the conversation Harmon argues lawmakers and industry advocates have been most reluctant to engage with. Veterans who lose their medical access because of a paperwork lapse, a renewal cost they cannot cover, or a recertification appointment they cannot make often do not simply stop treating their underlying condition. They go back to whatever was managing the chronic pain, the PTSD, the insomnia, the anxiety before. In a significant number of cases, that means opioids.

The amendment celebrated this week is silent on all of it. It removes one prohibition. It does not appropriate funds for training. It does not standardize state programs. It does not address recertification or renewal. It does not protect veterans whose access lapses for reasons unrelated to their medical need. It clears space for VA doctors to participate in a system that still functions, for most veterans, as an expensive obstacle course.

What functional access would actually require

Harmon argues that a system designed to actually deliver cannabis care to veterans would need three things the current bill does not provide: institutional buy-in inside the VA so that recommendations are not contingent on individual physician willingness, formal cannabinoid education built into provider training, and a federal mechanism that absorbs the renewal and recertification costs that currently push veterans out of compliance. None of those things are in the amendment. None of them are easy. All of them are the difference between policy that reads well and policy that reaches the veteran sitting at home with a paperwork problem they cannot solve.

The Mast-Joyce-Titus amendment is also not law yet. Similar veteran cannabis access provisions have passed the House and Senate in previous years and have been stripped out of final appropriations bills before reaching the president. The vote on May 14 was an amendment to a bill that still has to clear conference and be signed. The history of these provisions suggests that even the version Harmon is critiquing is not guaranteed to survive the legislative process.

That is what makes the celebration premature in more ways than one. The vote is real. The relief is symbolic. The infrastructure is missing. And the population of veterans the amendment is supposed to serve is, in most cases, still standing in a line that no one in Congress has agreed to shorten.